{"meta":{"query_hash":"13fea598a257","filters":{"venue":"Drug development & registration"},"cohort_total":29,"direct_labels_cover":0,"predictions_cover":29,"exported":29,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/13fea598a257","api":"https://metacan.xera.ac/api/v1/cohort?venue=Drug+development+%26+registration"},"results":[{"id":"W2911230576","doi":"10.33380/2305-2066-2019-8-1-113-117","title":"CERTIFICATION OF QUALITY MANAGEMENT SYSTEM OF LLC «CENTER OF PHARMACEUTICAL ANALYTICS» ACCORDING TO THE REQUIREMENTS OF ISO 9001:2015 (GOST R ISO 9001-2015) (REVIEW)","year":2019,"lang":"en","type":"article","venue":"Drug development & registration","topic":"Economic, Social, and Public Health Issues in Russia and Globally","field":"Decision Sciences","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Public Health Association","funders":"","keywords":"Certification; Quality management system; Audit; Accreditation; Quality audit; Certificate; Quality assurance; Business; Management system; Conformity assessment; Quality management; Engineering management; Accounting; Computer science; Operations management; Engineering; Medicine; Service (business); Management","score_opus":0.1793563772042008,"score_gpt":0.46201145828794593,"score_spread":0.28265508108374515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2911230576","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00056902046,0.9919991,0.0005950327,0.0017275402,0.0006332143,0.00012854596,0.00026751883,0.000027564263,0.0040525],"genre_scores_gemma":[0.011464885,0.9828857,0.001098297,0.0014058014,0.00044644883,0.00017369083,0.00082474976,0.000013245881,0.0016872102],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9948144,0.0007878891,0.00095626066,0.00048686247,0.0027720951,0.00018246865],"domain_scores_gemma":[0.9907369,0.0022066832,0.0023630462,0.00018352244,0.004302589,0.00020731184],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004731063,0.0005959098,0.0010138535,0.004871188,0.00040631293,0.0015130644,0.0012418417,0.0012629974,0.0058957315],"category_scores_gemma":[0.009889236,0.00029340893,0.0010127766,0.0038699626,0.00084393646,0.0020529386,0.0007913434,0.0012867802,0.0019802651],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009198641,0.00006761734,0.0014917753,0.06753052,0.00020182593,0.000119888595,0.00014539679,0.00022404762,0.0011764556,0.0037655577,0.08143066,0.84375435],"study_design_scores_gemma":[0.000048960315,0.00031737753,0.010053289,0.04495054,0.00035250754,0.0011583259,0.00020556094,0.00014846252,0.001342842,0.0010010098,0.9403767,0.000044334753],"about_ca_topic_score_codex":0.0053003915,"about_ca_topic_score_gemma":0.0063768807,"teacher_disagreement_score":0.0058957315,"about_ca_system_score_codex":0.0017458235,"about_ca_system_score_gemma":0.008482504,"threshold_uncertainty_score":0.02502054},"labels":[],"label_agreement":null},{"id":"W2947580881","doi":"10.33380/2305-2066-2019-8-2-108-114","title":"Development and Validation of Tadalafil Determination in Human Plasma by HPLC-MS Method","year":2019,"lang":"en","type":"article","venue":"Drug development & registration","topic":"Pharmaceutical Quality and Counterfeiting","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Public Health Association","funders":"","keywords":"Tadalafil; Protein precipitation; Chromatography; Calibration curve; Chemistry; Pharmacokinetics; High-performance liquid chromatography; Detection limit; Quantitative analysis (chemistry); Extraction (chemistry); Matrix (chemical analysis); Bioequivalence; Analyte; Erectile dysfunction; Pharmacology; Medicine","score_opus":0.04108518812559655,"score_gpt":0.35733628049779986,"score_spread":0.31625109237220334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2947580881","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.23494531,0.03537998,0.6937179,0.0016872331,0.0016439147,0.005464647,0.004615931,0.004164572,0.018380472],"genre_scores_gemma":[0.44003177,0.015644548,0.5155435,0.0024789793,0.0004989159,0.0068258494,0.0044326643,0.00025497447,0.0142887635],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99235934,0.0017933429,0.00061687955,0.0015202828,0.0034701275,0.0002399711],"domain_scores_gemma":[0.9981641,0.00043888186,0.00024229132,0.00012627244,0.0009670095,0.00006144268],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0041669663,0.0013727909,0.0009474457,0.0017548249,0.0012510945,0.001070773,0.0008890193,0.0021027094,0.0025220406],"category_scores_gemma":[0.004640925,0.0007425599,0.00085771264,0.00095035054,0.000974833,0.0006693747,0.000692416,0.0012731476,0.0021510455],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00080333784,0.0006779582,0.0074707055,0.0017815239,0.00030840977,0.00035535241,0.00045293308,0.001114593,0.8833815,0.0020910492,0.0024395117,0.09912307],"study_design_scores_gemma":[0.00028197945,0.0030037588,0.018319929,0.00039966745,0.00052149536,0.0030386327,0.00021879387,0.013428222,0.9094439,0.0010633342,0.050078668,0.00020157696],"about_ca_topic_score_codex":0.0014807477,"about_ca_topic_score_gemma":0.0020473027,"teacher_disagreement_score":0.0041669663,"about_ca_system_score_codex":0.0007800778,"about_ca_system_score_gemma":0.0033695383,"threshold_uncertainty_score":0.022037268},"labels":[],"label_agreement":null},{"id":"W2971404000","doi":"10.33380//2305-2066-2019-8-3-91-100","title":"A Comparative Parallel Study of Pharmacokinetics and Immunogenicity Following Single Intravenous Administration of Bevacizumab Biosimilar RPH-001 (Manufactured by R-Pharm Group, Russia) and Avastin® (Manufactured by F. Hoffmann-La Roche Ltd., Switzerland) in Healthy Male Volunteers","year":2019,"lang":"en","type":"article","venue":"Drug development & registration","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Public Health Association","funders":"","keywords":"Bevacizumab; Medicine; Pharmacokinetics; Immunogenicity; Biosimilar; Pharmacology; Antibody; Internal medicine; Immunology; Chemotherapy","score_opus":0.015063345169092792,"score_gpt":0.27465102252259677,"score_spread":0.25958767735350396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2971404000","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981602,0.0002427159,0.00072912127,0.00001403866,0.00003820739,0.00035337897,0.00012330803,0.0000145746235,0.0003244449],"genre_scores_gemma":[0.9960211,0.00024215002,0.0012942688,0.00008504774,0.000101111465,0.00061502383,0.0004957236,0.000013570754,0.0011318657],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9993461,0.00020260844,0.000037891845,0.00021830968,0.00013176705,0.00006333791],"domain_scores_gemma":[0.9989617,0.00021741846,0.00020543269,0.00021042797,0.00016546508,0.00023964366],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013475554,0.00067245093,0.0007504431,0.00026012518,0.00024689696,0.00035907124,0.00025038078,0.00056291994,0.0017461227],"category_scores_gemma":[0.0015123585,0.00037091717,0.00055369246,0.00018425182,0.00063385506,0.00037655586,0.00023746563,0.0007141604,0.000556828],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.44449607,0.08323894,0.025967376,0.0006351028,0.00067564414,0.00044226655,0.001123084,0.0010778122,0.37124947,0.0003600553,0.00084475655,0.06988939],"study_design_scores_gemma":[0.015728246,0.8476996,0.0862456,0.000014831964,0.00056966883,0.0008070385,0.00012180045,0.0016697128,0.044371396,0.00023111723,0.0024908371,0.000050141636],"about_ca_topic_score_codex":0.00021687507,"about_ca_topic_score_gemma":0.00014210682,"teacher_disagreement_score":0.0017461227,"about_ca_system_score_codex":0.00022256038,"about_ca_system_score_gemma":0.00034583677,"threshold_uncertainty_score":0.0071266294},"labels":[],"label_agreement":null},{"id":"W2972024183","doi":"10.33380/2305-2066-2019-8-3-79-84","title":"Development and Validation of HPLC-MS/MS Method for Busereline Quantitation in Animal Blood Plasma","year":2019,"lang":"en","type":"article","venue":"Drug development & registration","topic":"Hormonal and reproductive studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Public Health Association","funders":"","keywords":"Protein precipitation; Chromatography; High-performance liquid chromatography; Chemistry; Sample preparation; Pharmacokinetics; Extraction (chemistry); Pharmacology; Medicine","score_opus":0.03168130250184206,"score_gpt":0.3088721256624127,"score_spread":0.27719082316057064,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2972024183","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.51379013,0.026715597,0.4366667,0.0011415356,0.0009910531,0.002314985,0.0054802075,0.0037372266,0.009162544],"genre_scores_gemma":[0.5719846,0.015713332,0.3878748,0.0026326987,0.00032777464,0.0038819956,0.0051550088,0.00035196237,0.012077842],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979401,0.00039316237,0.000113669375,0.000588923,0.00085189944,0.0001122835],"domain_scores_gemma":[0.9991467,0.00016965721,0.00019555046,0.000053657015,0.00038151877,0.0000529477],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018483493,0.0009669754,0.0006370756,0.0011476568,0.00055295514,0.00056041393,0.000581203,0.0014770882,0.0013816193],"category_scores_gemma":[0.0019924166,0.00044062792,0.0006565927,0.0005601816,0.0005909131,0.000490874,0.00035563184,0.0008673444,0.0011990269],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037231288,0.0001089532,0.0030880324,0.0004954313,0.00010722671,0.00019406012,0.00009460487,0.00038024018,0.9754878,0.00023637112,0.00059611315,0.018838827],"study_design_scores_gemma":[0.00007078677,0.0019223726,0.0124627445,0.00013853933,0.0002140227,0.0017648845,0.00008378389,0.005285247,0.95967615,0.00029992635,0.017989254,0.00009214795],"about_ca_topic_score_codex":0.001211678,"about_ca_topic_score_gemma":0.0020445755,"teacher_disagreement_score":0.0018483493,"about_ca_system_score_codex":0.00060301356,"about_ca_system_score_gemma":0.0011807773,"threshold_uncertainty_score":0.009775162},"labels":[],"label_agreement":null},{"id":"W2989685308","doi":"10.33380/2305-2066-2019-8-4-61-74","title":"Development and Validation of Salbutamol, Bromhexine, Ambroxol and Guauaifenesin Determination in Human Plasma by HPLC-MS/MS Method","year":2019,"lang":"en","type":"article","venue":"Drug development & registration","topic":"Pharmacological Effects and Assays","field":"Agricultural and Biological Sciences","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Public Health Association","funders":"","keywords":"Ambroxol; Chromatography; Chemistry; Salbutamol; Pharmacokinetics; Bioequivalence; High-performance liquid chromatography; Solid phase extraction; Pharmacology; Medicine; Anesthesia; Asthma","score_opus":0.016696855331731028,"score_gpt":0.26685921259953127,"score_spread":0.25016235726780023,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2989685308","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6516067,0.033772487,0.29684868,0.0012694902,0.00074151426,0.0029715127,0.0028145174,0.00174888,0.008226171],"genre_scores_gemma":[0.73989904,0.011225819,0.23450756,0.0014679452,0.00028144458,0.0028524746,0.0018444046,0.0000896892,0.007831718],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99721897,0.00050192757,0.00022342296,0.00051741465,0.0014464057,0.0000919135],"domain_scores_gemma":[0.9994017,0.00015622619,0.00011961144,0.000039101196,0.00024484764,0.00003853936],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014766882,0.0008347947,0.0004988123,0.0010263949,0.000535304,0.00051060267,0.00042773888,0.0014111062,0.0012833585],"category_scores_gemma":[0.0018676985,0.0003358598,0.0006070266,0.00039465667,0.00055606716,0.00033047172,0.00039204964,0.0005593901,0.00084980944],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00050793553,0.00022934156,0.0027985682,0.0006080486,0.00009524723,0.00025547278,0.00012975147,0.00037787805,0.96034753,0.00026495312,0.00032650656,0.03405872],"study_design_scores_gemma":[0.00012913012,0.0020459641,0.012314368,0.0001694477,0.00017907878,0.0025432296,0.00011013297,0.0039933994,0.9677674,0.0002916763,0.010393282,0.00006283751],"about_ca_topic_score_codex":0.0007918816,"about_ca_topic_score_gemma":0.0010971699,"teacher_disagreement_score":0.0014766882,"about_ca_system_score_codex":0.0004318822,"about_ca_system_score_gemma":0.0014048738,"threshold_uncertainty_score":0.0078095794},"labels":[],"label_agreement":null},{"id":"W2991632468","doi":"10.33380/2305-2066-2019-8-4-53-60","title":"Chemical and Toxicological Analysis of Antiretroviral Drugs","year":2019,"lang":"en","type":"article","venue":"Drug development & registration","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Public Health Association","funders":"","keywords":"Efavirenz; Nevirapine; Atazanavir; Ritonavir; Darunavir; Abacavir; Zidovudine; Medicine; Pharmacology; Lamivudine; Lopinavir; Urine; Human immunodeficiency virus (HIV); Virology; Internal medicine; Viral load; Antiretroviral therapy; Viral disease; Virus","score_opus":0.009202233969733001,"score_gpt":0.24868486596939834,"score_spread":0.23948263199966535,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2991632468","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5481181,0.16744012,0.13393387,0.0030446427,0.0025387064,0.001595761,0.021662554,0.001941391,0.119724795],"genre_scores_gemma":[0.8220979,0.047122765,0.08172373,0.0023124157,0.0005749598,0.0007799567,0.008588078,0.00015459322,0.03664558],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980981,0.000264639,0.000119195734,0.00031988483,0.0010852653,0.000112956586],"domain_scores_gemma":[0.99927896,0.00012579208,0.0001666835,0.000048703605,0.00033141288,0.000048444883],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007808365,0.00069890876,0.0003685605,0.00300562,0.00070892955,0.0006731812,0.0004862781,0.0007408225,0.004638441],"category_scores_gemma":[0.0011431708,0.00023898359,0.000783067,0.001122214,0.00040586447,0.00048242806,0.00051878067,0.0006630196,0.0015074357],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042277132,0.00042477707,0.052802175,0.0029745877,0.0005001719,0.0016320728,0.00031072224,0.001748038,0.70425487,0.0039773965,0.0070605297,0.2238918],"study_design_scores_gemma":[0.000054181666,0.0013731284,0.0764095,0.00062419334,0.0003734321,0.007781179,0.00043763936,0.0069239917,0.72055596,0.0037517268,0.18156181,0.00015324359],"about_ca_topic_score_codex":0.0017232717,"about_ca_topic_score_gemma":0.0022904496,"teacher_disagreement_score":0.004638441,"about_ca_system_score_codex":0.0005593395,"about_ca_system_score_gemma":0.0010898053,"threshold_uncertainty_score":0.015517116},"labels":[],"label_agreement":null},{"id":"W3008140779","doi":"10.33380/2305-2066-2020-9-1-99-108","title":"Development and Validation of Atazanavir and Ritonavir Determination in Human Plasma by HPLC-MS Method","year":2020,"lang":"en","type":"article","venue":"Drug development & registration","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Public Health Association","funders":"","keywords":"Atazanavir; Ritonavir; Pharmacokinetics; Chromatography; Human plasma; Protein precipitation; Therapeutic drug monitoring; Chemistry; Pharmacology; Human immunodeficiency virus (HIV); Medicine; Antiretroviral therapy; Viral load; Virology","score_opus":0.025053923488284408,"score_gpt":0.2949525593858599,"score_spread":0.2698986358975755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3008140779","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3285726,0.02363051,0.62007016,0.0010186211,0.0008881928,0.0036848886,0.0031776514,0.003734214,0.01522319],"genre_scores_gemma":[0.4263023,0.00977718,0.54565954,0.0012811251,0.00023305282,0.003758064,0.002769044,0.00017018287,0.010049581],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9953734,0.00095014425,0.0003925654,0.0009350983,0.0022068657,0.00014193566],"domain_scores_gemma":[0.9988569,0.00029359318,0.00018045555,0.00010058378,0.0005197259,0.00004859643],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002222857,0.0012021002,0.00074583315,0.0016397405,0.000819109,0.00070677226,0.00093594566,0.001781378,0.0015721717],"category_scores_gemma":[0.0028191763,0.0005631077,0.0008219285,0.00072402874,0.00066879543,0.0005386894,0.0005992445,0.0010047542,0.0015220048],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036276173,0.00040269725,0.0037436308,0.00084627187,0.00016807085,0.00033184714,0.0002279542,0.0009954512,0.9238783,0.0009772052,0.00082803506,0.06723787],"study_design_scores_gemma":[0.000116506766,0.0017536795,0.008358074,0.00019129159,0.0001902346,0.002464471,0.00013083477,0.00816974,0.9567934,0.0006189879,0.021097103,0.000115691524],"about_ca_topic_score_codex":0.0008880393,"about_ca_topic_score_gemma":0.0013786862,"teacher_disagreement_score":0.002222857,"about_ca_system_score_codex":0.00052288827,"about_ca_system_score_gemma":0.0021188073,"threshold_uncertainty_score":0.011755705},"labels":[],"label_agreement":null},{"id":"W3030930859","doi":"10.33380/2305-2066-2020-9-2-140-144","title":"Immunogenicity Assessment of Pegfilgrastim in Patients with Breast Cancer","year":2020,"lang":"en","type":"article","venue":"Drug development & registration","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Public Health Association","funders":"","keywords":"Pegfilgrastim; Medicine; Filgrastim; Immunogenicity; Neutropenia; Immunoassay; Internal medicine; Breast cancer; Cancer; Oncology; Antibody; Immunology; Chemotherapy","score_opus":0.011224525604323868,"score_gpt":0.265162422345945,"score_spread":0.25393789674162115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3030930859","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971181,0.0013824746,0.000303534,0.00007058006,0.000018616634,0.0000678206,0.00011870884,0.000011106518,0.00090911385],"genre_scores_gemma":[0.99871826,0.00030222881,0.00032252359,0.00008199381,0.000017171453,0.000047746264,0.00016388418,0.0000010917769,0.00034508933],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996754,0.00012739714,0.000030991006,0.00004476669,0.00008552943,0.000035869474],"domain_scores_gemma":[0.9996388,0.00008257427,0.00014832838,0.000018967137,0.000067875946,0.000043388358],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058040005,0.00017578278,0.00019345798,0.00024894564,0.00012832423,0.00021930276,0.00009364815,0.00023421778,0.0007351598],"category_scores_gemma":[0.00096802297,0.00007350542,0.0002100789,0.00016908413,0.000116167656,0.000092602866,0.00010491959,0.00023513133,0.0001805432],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009402382,0.0012978541,0.8751127,0.00046318225,0.00017890199,0.0006687585,0.00040611313,0.00041618972,0.037553705,0.00010814013,0.0012830333,0.07310899],"study_design_scores_gemma":[0.0003053421,0.015768366,0.9461856,0.00006525608,0.00025368753,0.004935511,0.00022019072,0.001205548,0.02498361,0.000098917204,0.0059608705,0.000017168573],"about_ca_topic_score_codex":0.00022109257,"about_ca_topic_score_gemma":0.00024896106,"teacher_disagreement_score":0.0007351598,"about_ca_system_score_codex":0.00017906484,"about_ca_system_score_gemma":0.0001571438,"threshold_uncertainty_score":0.0030694604},"labels":[],"label_agreement":null},{"id":"W3031640402","doi":"10.33380/2305-2066-2020-9-2-145-150","title":"Method of Estimating the Equivalence of Dissolution Profiles: a Modern View (Review)","year":2020,"lang":"en","type":"article","venue":"Drug development & registration","topic":"Drug Solubulity and Delivery Systems","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Public Health Association","funders":"","keywords":"Mahalanobis distance; Outlier; Similarity (geometry); Equivalence (formal languages); Dissolution; Statistics; Mathematics; Weibull distribution; Comparability; Dissolution testing; Sample (material); Computer science; Econometrics; Combinatorics; Chemistry; Chromatography; Artificial intelligence; Discrete mathematics","score_opus":0.16604727660008556,"score_gpt":0.4344404072342946,"score_spread":0.26839313063420905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3031640402","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009730313,0.99713945,0.0016808289,0.00026947187,0.00019549121,0.000020655954,0.000067998335,0.000014012486,0.0005147551],"genre_scores_gemma":[0.0020257966,0.99384683,0.0029935092,0.00023767565,0.00026303102,0.000057379937,0.000118600125,0.0000067389,0.00045051155],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980373,0.00047468193,0.0002534589,0.00035014006,0.0008271474,0.000057427344],"domain_scores_gemma":[0.9971322,0.0016063385,0.00045206933,0.00008975887,0.0006615284,0.00005809234],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028884823,0.0012343504,0.0036382778,0.006083392,0.00026631076,0.001852674,0.001930101,0.0016576832,0.0036037725],"category_scores_gemma":[0.005879496,0.0007219844,0.001779239,0.0058921883,0.0012802626,0.0022754052,0.00088571163,0.0022748227,0.0021289173],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000973137,0.00005687805,0.0005265713,0.04911288,0.00052430836,0.00015732835,0.00006224674,0.0008855762,0.0008013354,0.007367505,0.017532686,0.9228753],"study_design_scores_gemma":[0.00005976438,0.00042455163,0.007767252,0.01572256,0.0012051561,0.0031065647,0.000119518554,0.001312311,0.0013640237,0.00890832,0.9598571,0.00015291893],"about_ca_topic_score_codex":0.0025296935,"about_ca_topic_score_gemma":0.0015691306,"teacher_disagreement_score":0.006083392,"about_ca_system_score_codex":0.0013681125,"about_ca_system_score_gemma":0.0017568334,"threshold_uncertainty_score":0.015275955},"labels":[],"label_agreement":null},{"id":"W3109322209","doi":"10.33380/2305-2066-2020-9-4-146-154","title":"Development and Validation of Pomalidomide Determination in Human Plasma by HPLC-MS/MS Method","year":2020,"lang":"en","type":"article","venue":"Drug development & registration","topic":"Analytical Methods in Pharmaceuticals","field":"Chemistry","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Public Health Association","funders":"","keywords":"Pomalidomide; Protein precipitation; Chromatography; High-performance liquid chromatography; Detection limit; Multiple myeloma; Chemistry; Pharmacokinetics; Thalidomide; Pharmacology; Medicine; Internal medicine","score_opus":0.060066103925766626,"score_gpt":0.36677226588327055,"score_spread":0.30670616195750394,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3109322209","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.27274302,0.037529483,0.6404178,0.0015641083,0.0014509545,0.006230669,0.007512909,0.0061027957,0.026448239],"genre_scores_gemma":[0.41705182,0.014713241,0.5361709,0.0028256911,0.00035494994,0.005356112,0.0054155183,0.00034923005,0.017762495],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99535614,0.0007040668,0.000334071,0.001226993,0.0022048017,0.00017391794],"domain_scores_gemma":[0.99917585,0.0001653775,0.0001506657,0.00007057722,0.00038701826,0.000050455714],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020610127,0.0014881699,0.0007894472,0.0020754545,0.0012011972,0.0009166674,0.0008409162,0.0017907114,0.0029972685],"category_scores_gemma":[0.0028749958,0.0005803555,0.00074293755,0.0008353183,0.00086098065,0.00062729896,0.0006932499,0.0012721181,0.0020088502],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00073941884,0.0004391815,0.007214039,0.0012297994,0.00025368435,0.0004902803,0.0003165388,0.0012448533,0.91268665,0.001533563,0.002811346,0.071040615],"study_design_scores_gemma":[0.00014072986,0.001040322,0.007940341,0.00022737581,0.0002272906,0.00231376,0.00018572462,0.008551076,0.93958706,0.0008409477,0.038797922,0.00014750907],"about_ca_topic_score_codex":0.0019943633,"about_ca_topic_score_gemma":0.0031135366,"teacher_disagreement_score":0.0029972685,"about_ca_system_score_codex":0.00094036077,"about_ca_system_score_gemma":0.002897574,"threshold_uncertainty_score":0.010899782},"labels":[],"label_agreement":null},{"id":"W3129249197","doi":"10.33380/2305-2066-2021-10-1-120-128","title":"Development and Validation of Valganciclovir and its Active Metabolite Ganciclovir Determination in Human Plasma by HPLC-MS/MS Method","year":2021,"lang":"en","type":"article","venue":"Drug development & registration","topic":"Cytomegalovirus and herpesvirus research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Public Health Association","funders":"","keywords":"Valganciclovir; Ganciclovir; Chromatography; High-performance liquid chromatography; Protein precipitation; Chemistry; Pharmacokinetics; Detection limit; Active metabolite; Metabolite; Human cytomegalovirus; Pharmacology; Medicine; Biochemistry","score_opus":0.032049846437376066,"score_gpt":0.33493987102995376,"score_spread":0.3028900245925777,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3129249197","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3599156,0.059027366,0.552233,0.0015575299,0.0012721552,0.0041552754,0.004745052,0.0034482644,0.013645669],"genre_scores_gemma":[0.6129004,0.014871954,0.35526004,0.001928808,0.0002878926,0.0036057564,0.0027501376,0.00017863285,0.008216378],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9946516,0.0011928653,0.00039228427,0.0010795742,0.0024970325,0.00018679316],"domain_scores_gemma":[0.99906,0.00022095043,0.00015057453,0.000080842,0.00043492284,0.00005280187],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003307777,0.0013151485,0.0007827086,0.0015362076,0.0006701183,0.0007883087,0.00069594505,0.0019359352,0.0013279748],"category_scores_gemma":[0.0028612756,0.00055785745,0.0007424385,0.00064620236,0.00083280134,0.00047162306,0.0006076791,0.0011774511,0.0010775431],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006563878,0.00027013582,0.006138016,0.0010484287,0.00019295761,0.00033766704,0.00016809625,0.000916538,0.9209265,0.0006829168,0.00091624353,0.067745976],"study_design_scores_gemma":[0.00016017006,0.00184851,0.011774747,0.00025108238,0.00024718003,0.0029474606,0.00011162335,0.007917961,0.9542064,0.00062584726,0.019784978,0.00012397103],"about_ca_topic_score_codex":0.0015959775,"about_ca_topic_score_gemma":0.0017884517,"teacher_disagreement_score":0.003307777,"about_ca_system_score_codex":0.0007750527,"about_ca_system_score_gemma":0.0021722668,"threshold_uncertainty_score":0.017493367},"labels":[],"label_agreement":null},{"id":"W3130804109","doi":"10.33380/2305-2066-2021-10-1-83-89","title":"Isolation of Individual Compounds from the Terrestrial Parts of Ononis Arvensis L. and Solidago Canadensis L.","year":2021,"lang":"en","type":"article","venue":"Drug development & registration","topic":"Medicinal plant effects and applications","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Saint petersburg; Traditional medicine; Botany; Solidago canadensis; Biology; Isolation (microbiology); Chemistry; Invasive species","score_opus":0.027100276456940214,"score_gpt":0.26260469248008633,"score_spread":0.23550441602314612,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3130804109","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87237865,0.06723773,0.015497958,0.00072320126,0.0004418786,0.00095327117,0.008212583,0.000376736,0.034177944],"genre_scores_gemma":[0.93291456,0.023546634,0.016527073,0.0007243592,0.0002374643,0.00043373523,0.013905103,0.0000765843,0.011634614],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99989104,0.000011779373,0.000008272561,0.00003229921,0.00003693998,0.000019642768],"domain_scores_gemma":[0.99986637,0.00002913425,0.000020490805,0.00001437507,0.00003583205,0.00003377348],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000085179905,0.0010889792,0.00048548455,0.002063958,0.00044477556,0.00032366414,0.00022338802,0.0003010612,0.002118883],"category_scores_gemma":[0.0001850958,0.00015486803,0.0005214712,0.0011149097,0.00028506562,0.00034786342,0.00032390523,0.0006004557,0.00071027636],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003818343,0.0002209837,0.0022653928,0.0010689254,0.000107679545,0.0009391377,0.00020664507,0.00021214718,0.9437905,0.00024741588,0.0004592047,0.05010024],"study_design_scores_gemma":[0.00036784273,0.0046414128,0.21079995,0.00066861714,0.0012796489,0.006588205,0.0013346702,0.0011880572,0.6030338,0.0018157591,0.16814345,0.00013856468],"about_ca_topic_score_codex":0.001584406,"about_ca_topic_score_gemma":0.0028281396,"teacher_disagreement_score":0.002118883,"about_ca_system_score_codex":0.00013806042,"about_ca_system_score_gemma":0.0004047918,"threshold_uncertainty_score":0.007088363},"labels":[],"label_agreement":null},{"id":"W3132138449","doi":"10.33380/2305-2066-2021-10-1-31-36","title":"PD-L1 as a Potential Target in Cancer Therapy (Review)","year":2021,"lang":"en","type":"article","venue":"Drug development & registration","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Public Health Association","funders":"","keywords":"Durvalumab; Avelumab; Immunotherapy; Immune system; Cancer; Medicine; Clinical trial; Cancer immunotherapy; Mechanism (biology); Immunology; Cancer research; Internal medicine; Nivolumab","score_opus":0.019832939404268567,"score_gpt":0.3036877309930628,"score_spread":0.28385479158879423,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3132138449","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013111788,0.9979091,0.0001063846,0.0004335492,0.00051015394,0.00001078594,0.000049595692,0.000010045196,0.00083910994],"genre_scores_gemma":[0.001035508,0.99702066,0.00016277627,0.0004860378,0.00035530012,0.000015658035,0.000097251,0.0000017104713,0.00082506385],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998241,0.00002934021,0.00002512331,0.00003617605,0.000063897314,0.000021408778],"domain_scores_gemma":[0.9997826,0.000073528776,0.0000457966,0.000005459629,0.000073051815,0.00001956455],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033686575,0.0007589184,0.0010887033,0.0013312637,0.0002501221,0.0011474224,0.0007385066,0.00094876956,0.0065396307],"category_scores_gemma":[0.0005530548,0.000178044,0.0008002788,0.00130907,0.00023788738,0.0009595878,0.0004645094,0.0017168736,0.0017643136],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000119172735,0.000057878824,0.000118941774,0.033705812,0.00014794641,0.00013614132,0.00003626039,0.00041277357,0.0010442565,0.001919592,0.07928044,0.8830209],"study_design_scores_gemma":[0.000037115016,0.00013722968,0.0006406329,0.0080882395,0.00026883362,0.0010461261,0.00003968523,0.000113577036,0.00038575497,0.0011541492,0.98807037,0.000018348243],"about_ca_topic_score_codex":0.0008590839,"about_ca_topic_score_gemma":0.0014684784,"teacher_disagreement_score":0.0065396307,"about_ca_system_score_codex":0.00063148537,"about_ca_system_score_gemma":0.0012083263,"threshold_uncertainty_score":0.021877289},"labels":[],"label_agreement":null},{"id":"W3169402917","doi":"10.33380/2305-2066-2021-10-2-120-127","title":"Development and Validation of Tranexamic Acid Determination in Human Plasma by HPLC-MS/MS method","year":2021,"lang":"en","type":"article","venue":"Drug development & registration","topic":"Blood transfusion and management","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Public Health Association","funders":"","keywords":"Tranexamic acid; Chromatography; High-performance liquid chromatography; Protein precipitation; Pharmacokinetics; Chemistry; Calibration curve; Bioequivalence; Selected reaction monitoring; Tandem mass spectrometry; Detection limit; Mass spectrometry; Pharmacology; Medicine; Blood loss; Surgery","score_opus":0.020985831172852215,"score_gpt":0.28695898020178245,"score_spread":0.2659731490289302,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3169402917","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.34830192,0.03922951,0.57719356,0.0014789398,0.001447281,0.00568395,0.0049327384,0.00380274,0.017929293],"genre_scores_gemma":[0.5139732,0.016016854,0.44401795,0.0021651015,0.00036435586,0.0065125762,0.0036827002,0.00023690936,0.013030336],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9944253,0.0011704571,0.00050194305,0.0011639092,0.0025476578,0.00019076881],"domain_scores_gemma":[0.998601,0.00025747044,0.00026708402,0.00010768963,0.0007005798,0.000066164444],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030491538,0.0014603601,0.000983098,0.0015930883,0.0010793066,0.00079235143,0.0007547767,0.001844985,0.002621032],"category_scores_gemma":[0.003606174,0.00057604373,0.00076735124,0.000869369,0.0009345195,0.0007130933,0.00078098045,0.0010735374,0.0017580062],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007184933,0.00036910237,0.0047523943,0.001246713,0.00020570635,0.00045769472,0.00022576272,0.0007500246,0.9109322,0.001084905,0.0013098726,0.077947296],"study_design_scores_gemma":[0.00018893689,0.0022218907,0.011736478,0.00026098243,0.00030857354,0.0038461664,0.00014239376,0.0073952843,0.94437253,0.00062600285,0.028745206,0.00015553995],"about_ca_topic_score_codex":0.0013192432,"about_ca_topic_score_gemma":0.0017196964,"teacher_disagreement_score":0.0030491538,"about_ca_system_score_codex":0.00073295966,"about_ca_system_score_gemma":0.0029308647,"threshold_uncertainty_score":0.01612562},"labels":[],"label_agreement":null},{"id":"W3172267348","doi":"10.33380/2305-2066-2021-10-2-87-99","title":"HPLC-UV Method Development and Validation for Vitamin D<sub>3</sub> (Cholecalciferol) Quantitation in Drugs and Dietary Supplements","year":2021,"lang":"en","type":"article","venue":"Drug development & registration","topic":"Vitamin D Research Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Public Health Association","funders":"","keywords":"Cholecalciferol; Vitamin D and neurology; Vitamin; Chromatography; High-performance liquid chromatography; Chemistry; Extraction (chemistry); Medicine; Biochemistry; Internal medicine","score_opus":0.04060706993902249,"score_gpt":0.34464147568001974,"score_spread":0.30403440574099727,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3172267348","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.14737621,0.021140134,0.7987875,0.000667796,0.0007937887,0.004468139,0.0031520997,0.0046002185,0.019014107],"genre_scores_gemma":[0.31202826,0.0117626125,0.650262,0.0010894994,0.0002108384,0.0062434785,0.0034771275,0.00040874156,0.014517443],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9932954,0.001707762,0.0005137666,0.0011631529,0.0030812784,0.00023867554],"domain_scores_gemma":[0.99774325,0.0005544075,0.00030184016,0.00023092555,0.0010780158,0.00009151475],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0037161221,0.0014271181,0.00090853084,0.0022692461,0.001399961,0.0007803005,0.0010021047,0.0014759256,0.0033863634],"category_scores_gemma":[0.004051795,0.0008100758,0.00096724625,0.0011346153,0.0010179771,0.00070664735,0.0008300102,0.0012675438,0.0033311476],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034328754,0.0004301116,0.0043401304,0.0015546429,0.00018493437,0.0002774706,0.00019954206,0.0013676638,0.88770753,0.0016026209,0.0024027948,0.09958921],"study_design_scores_gemma":[0.00009862544,0.0012088376,0.010038925,0.0003021483,0.0002211606,0.0017748601,0.00013001956,0.0066005965,0.9327969,0.0005796185,0.04612638,0.000121833786],"about_ca_topic_score_codex":0.0037301714,"about_ca_topic_score_gemma":0.0048365816,"teacher_disagreement_score":0.0037301714,"about_ca_system_score_codex":0.0012060123,"about_ca_system_score_gemma":0.004533237,"threshold_uncertainty_score":0.019652963},"labels":[],"label_agreement":null},{"id":"W3197910357","doi":"10.33380/2305-2066-2021-10-3-55-69","title":"Development of a Gastro-retentive Dosage Form of a New Promising Anti-tuberculosis Drug Macozinone","year":2021,"lang":"en","type":"article","venue":"Drug development & registration","topic":"Pharmacological Effects of Natural Compounds","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Public Health Association","funders":"","keywords":"Bioavailability; Mucoadhesion; Drug; Dosage form; Pharmacology; Tuberculosis; Lipophilicity; Active ingredient; Chemistry; Medicine; Drug carrier; Stereochemistry","score_opus":0.08563882169745975,"score_gpt":0.3943502260694476,"score_spread":0.30871140437198785,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3197910357","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9631287,0.010871765,0.019441137,0.0002630975,0.00012411678,0.00077826035,0.00083002605,0.00019650745,0.004366426],"genre_scores_gemma":[0.95132154,0.0058833132,0.037325293,0.000091662696,0.000034067783,0.0002035141,0.00064874016,0.000034850807,0.00445704],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998851,0.00001464576,0.0000115158455,0.000027995902,0.000050717048,0.000009985054],"domain_scores_gemma":[0.9999243,0.00001084094,0.000028246495,0.000006946563,0.000015881367,0.000013780731],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016535482,0.0002661455,0.000273742,0.00030548955,0.000097221586,0.00025318004,0.0002442489,0.00030626878,0.0013918596],"category_scores_gemma":[0.00024339758,0.00013130959,0.00026163796,0.00013376013,0.00016492102,0.00029324,0.00013982807,0.00031020446,0.00033584845],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017859522,0.000060420665,0.00013503386,0.00026864067,0.000013292279,0.00008051299,0.000023334505,0.00011304408,0.98643965,0.00015179181,0.00008495646,0.012450739],"study_design_scores_gemma":[0.00014854221,0.0025564013,0.0034007782,0.000032036423,0.00006774659,0.00053138274,0.000024011686,0.000992924,0.975657,0.000029168079,0.016541941,0.000018127754],"about_ca_topic_score_codex":0.0003743386,"about_ca_topic_score_gemma":0.0006144915,"teacher_disagreement_score":0.0013918596,"about_ca_system_score_codex":0.00016348029,"about_ca_system_score_gemma":0.00018970584,"threshold_uncertainty_score":0.0046562552},"labels":[],"label_agreement":null},{"id":"W3198549098","doi":"10.33380/2305-2066-2021-10-3-105-113","title":"Determination of Lappaconitin, Diterpene Alkaloide Obtained from Plants <i>Aconitum leucostomum</i>, and its Active Metabolite N-desacetyllappaconitin in Human Plasma and Blood","year":2021,"lang":"en","type":"article","venue":"Drug development & registration","topic":"Plant-based Medicinal Research","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Public Health Association","funders":"","keywords":"Alkaloid; Chemistry; Chromatography; Diterpene; High-performance liquid chromatography; Protein precipitation; Pharmacokinetics; Metabolite; Aconitum; Quantitative analysis (chemistry); Active metabolite; Pharmacology; Stereochemistry; Biochemistry; Medicine","score_opus":0.056250910114366164,"score_gpt":0.3656614644053199,"score_spread":0.3094105542909537,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3198549098","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9143855,0.021261241,0.056324612,0.0003463926,0.0001296625,0.00029933715,0.0016536604,0.0006047102,0.0049948464],"genre_scores_gemma":[0.9510792,0.0053320406,0.036854986,0.00031219138,0.00004422983,0.0002536041,0.0012282433,0.00002527013,0.0048702257],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997105,0.000042556178,0.000020005076,0.0000882142,0.00012393658,0.000014719285],"domain_scores_gemma":[0.999863,0.000029988134,0.000036010442,0.000011039216,0.00004276925,0.000017169672],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023099096,0.00035289285,0.00014551458,0.00040769298,0.00018667911,0.00016079722,0.00017703406,0.00042824112,0.0008155746],"category_scores_gemma":[0.00040179826,0.000120133154,0.00014384888,0.00023218265,0.00019249639,0.00018601246,0.0001276379,0.0002554895,0.0002624334],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035428113,0.00004747128,0.0040860153,0.00020673592,0.000031224692,0.00016046864,0.000052381107,0.00012806883,0.9739213,0.00009657303,0.00015671387,0.020758746],"study_design_scores_gemma":[0.00004069984,0.00090217276,0.02376184,0.000037657144,0.000068739995,0.0022893597,0.000059552745,0.002415414,0.96476525,0.00012074006,0.0055172523,0.000021225234],"about_ca_topic_score_codex":0.00093236146,"about_ca_topic_score_gemma":0.001603444,"teacher_disagreement_score":0.00093236146,"about_ca_system_score_codex":0.00019193428,"about_ca_system_score_gemma":0.00031904996,"threshold_uncertainty_score":0.002728343},"labels":[],"label_agreement":null},{"id":"W3217107789","doi":"10.33380/2305-2066-2020-9-2-133-139","title":"Development and Validation of Valganciclovir and its Active Metabolite Ganciclovir Determination in Human Plasma by HPLC-UV Method","year":2020,"lang":"en","type":"article","venue":"Drug development & registration","topic":"Cytomegalovirus and herpesvirus research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Public Health Association","funders":"","keywords":"Valganciclovir; Ganciclovir; Prodrug; Active metabolite; Protein precipitation; High-performance liquid chromatography; Pharmacokinetics; Metabolite; Chromatography; Human cytomegalovirus; Chemistry; Pharmacology; Biology; Biochemistry","score_opus":0.04124204494144324,"score_gpt":0.3327477137431953,"score_spread":0.29150566880175205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3217107789","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.28557733,0.03238806,0.6540424,0.0014033819,0.0010998591,0.0035453204,0.0031537095,0.0044249315,0.014364945],"genre_scores_gemma":[0.45930222,0.011559586,0.50905305,0.0016425067,0.00023994748,0.0039301165,0.0028812175,0.00026683585,0.011124488],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99370825,0.00153091,0.0004374042,0.0013784533,0.0026964056,0.0002486227],"domain_scores_gemma":[0.9986222,0.00039626824,0.00020196916,0.00013145503,0.00057640555,0.00007161783],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0037419596,0.0014116883,0.0007988471,0.0016770031,0.00090995117,0.0009729489,0.0010040011,0.0021378817,0.0016335525],"category_scores_gemma":[0.004279466,0.00072897,0.00089977303,0.0008602471,0.00093839277,0.00067357364,0.00072462583,0.001454029,0.0015123341],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005752247,0.00052016205,0.005707648,0.0011873405,0.00018708358,0.0002714346,0.00038467904,0.0012571984,0.9137549,0.0011891695,0.0012341125,0.07373114],"study_design_scores_gemma":[0.000114260234,0.0017104541,0.0066688415,0.00021882475,0.0001914415,0.00190309,0.00017740398,0.006371196,0.96181554,0.00056078844,0.020155564,0.00011248064],"about_ca_topic_score_codex":0.0016936274,"about_ca_topic_score_gemma":0.0022406422,"teacher_disagreement_score":0.0037419596,"about_ca_system_score_codex":0.0007982418,"about_ca_system_score_gemma":0.0026518789,"threshold_uncertainty_score":0.019789636},"labels":[],"label_agreement":null},{"id":"W3217188055","doi":"10.33380/2305-2066-2021-10-4-177-189","title":"Simultaneous Determination of Candesartan and Hydrochlorothiazide in Human Plasma by HPLC-MS/MS","year":2021,"lang":"en","type":"article","venue":"Drug development & registration","topic":"Analytical Methods in Pharmaceuticals","field":"Chemistry","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Public Health Association","funders":"","keywords":"Candesartan; Hydrochlorothiazide; Chromatography; Chemistry; Valsartan; High-performance liquid chromatography; Indapamide; Formic acid; Angiotensin II; Pharmacology; Diuretic; Medicine; Internal medicine; Blood pressure","score_opus":0.021959117761044037,"score_gpt":0.32421242551069546,"score_spread":0.3022533077496514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3217188055","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5846048,0.069938384,0.30598062,0.0019913546,0.0014757557,0.0021242849,0.008885457,0.0077398294,0.017259534],"genre_scores_gemma":[0.6821345,0.017050637,0.28049865,0.0035345189,0.00059526705,0.002526549,0.0037584738,0.00028690376,0.009614501],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9971879,0.00044903695,0.00017627524,0.00092384167,0.0011383583,0.00012457444],"domain_scores_gemma":[0.9993474,0.00022138272,0.0001217176,0.00004837138,0.00021238273,0.000048717575],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018337386,0.0011695465,0.0009705149,0.0015445035,0.0006941381,0.0006858423,0.0006096189,0.0018683936,0.0017420707],"category_scores_gemma":[0.0018104782,0.00049789145,0.0005561485,0.0008650108,0.0006506444,0.0005142667,0.0005009801,0.00080469606,0.0012021879],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010397185,0.00021593657,0.004616049,0.0008736566,0.00032709283,0.00032325526,0.00010193615,0.0004415006,0.9330543,0.00030225533,0.0018785738,0.05682568],"study_design_scores_gemma":[0.00038564822,0.0021214935,0.027562547,0.00018652181,0.0005348383,0.005399615,0.00013961154,0.010716825,0.9326657,0.00071942015,0.019403942,0.0001637947],"about_ca_topic_score_codex":0.0010229708,"about_ca_topic_score_gemma":0.0016289488,"teacher_disagreement_score":0.0018683936,"about_ca_system_score_codex":0.00056304946,"about_ca_system_score_gemma":0.001383346,"threshold_uncertainty_score":0.0096978545},"labels":[],"label_agreement":null},{"id":"W4213452411","doi":"10.33380/2305-2066-2022-11-1-140-147","title":"Pharmacokinetics Study of the Long-acting Antiarrhythmic Drug of Lappaconitine Hydrobromide (Allaforte®, JSC \"Pharmcenter VILAR\", Russia)","year":2022,"lang":"en","type":"article","venue":"Drug development & registration","topic":"Plant-based Medicinal Research","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Public Health Association","funders":"","keywords":"Pharmacokinetics; Cmax; Pharmacology; Drug; Plasma concentration; Alkaloid; Chemistry; Medicine; Stereochemistry","score_opus":0.08764112469374505,"score_gpt":0.4045696862444642,"score_spread":0.31692856155071913,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4213452411","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97998124,0.008679801,0.0077654887,0.00015548768,0.000040504718,0.00009432748,0.00057134347,0.00015078779,0.0025609415],"genre_scores_gemma":[0.9935915,0.0018613082,0.0024515719,0.00007080873,0.000014883749,0.000041040952,0.0004230157,0.000019166033,0.0015266795],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998766,0.00003649889,0.000006992145,0.00003377711,0.00003160885,0.000014502506],"domain_scores_gemma":[0.99992704,0.000019005947,0.000019450576,0.000008035261,0.000011654712,0.00001474466],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017812721,0.00016396455,0.00022758216,0.00010111084,0.00006349215,0.00014967733,0.000101328886,0.00012835201,0.0012442291],"category_scores_gemma":[0.00028957246,0.00011508328,0.00018740498,0.00009912729,0.00009279946,0.00012730472,0.00006780897,0.0002766362,0.00023924255],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007939968,0.00047171462,0.009855983,0.0003467531,0.00023675144,0.0002808786,0.00014606572,0.0019256935,0.8882974,0.00037402703,0.0009583629,0.0891664],"study_design_scores_gemma":[0.001310364,0.039868135,0.19921216,0.0000781017,0.0005255824,0.0058074864,0.00015848548,0.020419177,0.6992712,0.00053904334,0.0327097,0.000100544],"about_ca_topic_score_codex":0.0005747221,"about_ca_topic_score_gemma":0.00054213434,"teacher_disagreement_score":0.0012442291,"about_ca_system_score_codex":0.00014911704,"about_ca_system_score_gemma":0.00021475111,"threshold_uncertainty_score":0.0041623116},"labels":[],"label_agreement":null},{"id":"W4281633450","doi":"10.33380/2305-2066-2022-11-2-180-186","title":"Phase I Pharmacokinetics Study of Drug «COVID-globulin» (Specific Human Immunoglobulin Against COVID-19)","year":2022,"lang":"en","type":"article","venue":"Drug development & registration","topic":"SARS-CoV-2 and COVID-19 Research","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Public Health Association","funders":"","keywords":"Pharmacokinetics; Antibody; Medicine; Virology; Immunoglobulin G; Drug; Polyclonal antibodies; Antiviral drug; Coronavirus disease 2019 (COVID-19); Immunology; Pharmacology; Infectious disease (medical specialty); Disease; Internal medicine","score_opus":0.07213643085207633,"score_gpt":0.3924006549297945,"score_spread":0.32026422407771815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281633450","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98163706,0.003096042,0.004505148,0.0004472807,0.00032078123,0.0036573992,0.0023246815,0.00031610718,0.0036954754],"genre_scores_gemma":[0.9796593,0.002002128,0.0031446272,0.0009955578,0.00017522134,0.0025455514,0.0034240878,0.00009962506,0.007953939],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99970067,0.00010459869,0.000008957706,0.000075262986,0.000040703453,0.000069773705],"domain_scores_gemma":[0.99967384,0.000041019637,0.0000648951,0.000041919007,0.000049291866,0.00012897035],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006169448,0.0011433157,0.0009246203,0.00028996894,0.000265418,0.00080005615,0.0005776145,0.000893015,0.002712304],"category_scores_gemma":[0.0005750021,0.00045440038,0.00071317866,0.00022077028,0.0005455192,0.00042773274,0.00017271329,0.0020562627,0.0007797297],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.37601444,0.10689031,0.0074921874,0.000958881,0.0012590755,0.00040425122,0.00038905872,0.006084933,0.3660979,0.0015340478,0.012104428,0.120770454],"study_design_scores_gemma":[0.10596229,0.7547513,0.016232504,0.000068273795,0.0008259992,0.0009650667,0.000101208796,0.0046896185,0.08683127,0.0006174094,0.028886115,0.00006899747],"about_ca_topic_score_codex":0.00066781073,"about_ca_topic_score_gemma":0.0007460094,"teacher_disagreement_score":0.002712304,"about_ca_system_score_codex":0.0008110316,"about_ca_system_score_gemma":0.0015313494,"threshold_uncertainty_score":0.0090735555},"labels":[],"label_agreement":null},{"id":"W4294681241","doi":"10.33380/2305-2066-2022-11-3-220-229","title":"Development and Validation of HPLC-UV Method for the Determination of Favipiravir in Human Plasma","year":2022,"lang":"en","type":"article","venue":"Drug development & registration","topic":"Antibiotics Pharmacokinetics and Efficacy","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Public Health Association","funders":"","keywords":"Favipiravir; Chromatography; High-performance liquid chromatography; Chemistry; Pharmacokinetics; Protein precipitation; Therapeutic drug monitoring; Formic acid; Pharmacology; Medicine; Coronavirus disease 2019 (COVID-19)","score_opus":0.03748672329783132,"score_gpt":0.33831060084608994,"score_spread":0.3008238775482586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4294681241","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.22439553,0.058770496,0.6857169,0.00136834,0.0013999818,0.0034408132,0.0031898099,0.006934902,0.014783302],"genre_scores_gemma":[0.3970432,0.015536258,0.56736314,0.0022713456,0.00035281194,0.0043331785,0.0032144745,0.0003586775,0.009526995],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99459994,0.0013710216,0.00037752747,0.0014478603,0.0020028022,0.00020089398],"domain_scores_gemma":[0.99840826,0.00052286504,0.00021724371,0.00012575585,0.0006341244,0.000091789785],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032940032,0.0015561226,0.0009740991,0.0020301521,0.0011085232,0.0009737845,0.0011769924,0.002812181,0.0021452091],"category_scores_gemma":[0.0039698463,0.0010020861,0.0010686223,0.0009263346,0.0009570536,0.00069647224,0.00075804023,0.0014104942,0.0024132149],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005613454,0.00044155278,0.0044997493,0.0015935145,0.0002249455,0.00034390495,0.00029663992,0.001002526,0.9188322,0.00077470543,0.0015430752,0.06988586],"study_design_scores_gemma":[0.00031861363,0.0033728278,0.021414982,0.00060426106,0.00050172803,0.007015533,0.00030424283,0.012143321,0.9134366,0.00097568595,0.039664563,0.00024766725],"about_ca_topic_score_codex":0.0017918242,"about_ca_topic_score_gemma":0.0024947394,"teacher_disagreement_score":0.0032940032,"about_ca_system_score_codex":0.0008585124,"about_ca_system_score_gemma":0.002379253,"threshold_uncertainty_score":0.01742059},"labels":[],"label_agreement":null},{"id":"W4313415459","doi":"10.33380/2305-2066-2022-11-4(1)-120-127","title":"Development and Validation of the ELISA Method for Anti-trastuzumab Antibodies Determination in Human Serum","year":2022,"lang":"en","type":"article","venue":"Drug development & registration","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Public Health Association","funders":"","keywords":"Trastuzumab; Antibody; Medicine; Monoclonal antibody; Immunogenicity; Pharmacology; Internal medicine; Immunology; Cancer; Breast cancer","score_opus":0.037261346888283316,"score_gpt":0.34628905501674784,"score_spread":0.30902770812846453,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4313415459","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.20218745,0.013204161,0.7657727,0.00077191886,0.0008096019,0.0018766028,0.001254385,0.0023232964,0.011799899],"genre_scores_gemma":[0.45080653,0.0073577925,0.5215979,0.0010299119,0.00023983342,0.0021594437,0.0022056564,0.0001465938,0.014456229],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9934169,0.0014838862,0.0003211667,0.0009304746,0.0036661148,0.0001815369],"domain_scores_gemma":[0.9980445,0.00037881237,0.00025088055,0.00016529553,0.0010808854,0.00007955714],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028260024,0.0009018605,0.0005667544,0.0014771945,0.0003832474,0.0006715344,0.00087625673,0.0013309764,0.0013091492],"category_scores_gemma":[0.0038111797,0.00045511045,0.0006612098,0.0005824155,0.00056477834,0.00042854145,0.0005440709,0.0010750403,0.0015219338],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020298579,0.00031261967,0.0030805,0.000513401,0.000057460937,0.00020368565,0.00012863873,0.0005685262,0.9445779,0.0007213233,0.0007158202,0.048917163],"study_design_scores_gemma":[0.00003802902,0.00081056845,0.006237047,0.00011460389,0.00007732591,0.001438002,0.000055587305,0.006912129,0.9690514,0.00026255668,0.014955173,0.000047667472],"about_ca_topic_score_codex":0.00067296915,"about_ca_topic_score_gemma":0.0010876978,"teacher_disagreement_score":0.0028260024,"about_ca_system_score_codex":0.00047037154,"about_ca_system_score_gemma":0.0011336209,"threshold_uncertainty_score":0.014945507},"labels":[],"label_agreement":null},{"id":"W4322752875","doi":"10.33380/2305-2066-2023-12-1-215-226","title":"Simultaneous Determination of Major Molnupiravir Metabolite (β-D-N4-hydroxycytidine) and Favipiravir in Human Plasma by HPLC-MS/MS","year":2023,"lang":"en","type":"article","venue":"Drug development & registration","topic":"Antibiotics Pharmacokinetics and Efficacy","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Public Health Association","funders":"","keywords":"Favipiravir; Chromatography; Chemistry; High-performance liquid chromatography; Formic acid; Ammonium formate; Electrospray ionization; Tandem mass spectrometry; Selected reaction monitoring; Triethylamine; Mass spectrometry; Medicine; Coronavirus disease 2019 (COVID-19)","score_opus":0.014596228474675564,"score_gpt":0.28706257507463406,"score_spread":0.2724663465999585,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322752875","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8022027,0.035050858,0.14376426,0.0006297467,0.00041922956,0.001055495,0.0037478337,0.0027775671,0.01035231],"genre_scores_gemma":[0.88435245,0.0071350206,0.10102188,0.00091805967,0.00009758892,0.00081133033,0.0016510731,0.00009187656,0.003920657],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999047,0.00018062713,0.00006580538,0.00033633542,0.000312392,0.000057757177],"domain_scores_gemma":[0.999739,0.0000678821,0.000057144476,0.000015216809,0.00009371483,0.000027100466],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006522329,0.0008139694,0.00041055237,0.00084994186,0.00048498265,0.00043282312,0.00038716558,0.0010337102,0.0009394819],"category_scores_gemma":[0.0007841181,0.00035584683,0.00032324353,0.00041517842,0.00034407573,0.0002550502,0.00029400256,0.00046743828,0.00058319484],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007252096,0.00012517448,0.0052116537,0.00042322767,0.00013771663,0.00030912808,0.000112510206,0.00044354284,0.9654655,0.00016046532,0.00044801043,0.026437774],"study_design_scores_gemma":[0.00014474156,0.0017035225,0.025522213,0.00010756751,0.00023332036,0.005006707,0.00015733889,0.009740351,0.9459707,0.00034513968,0.010975691,0.00009258628],"about_ca_topic_score_codex":0.0013706145,"about_ca_topic_score_gemma":0.001941754,"teacher_disagreement_score":0.0013706145,"about_ca_system_score_codex":0.00038935806,"about_ca_system_score_gemma":0.0008400833,"threshold_uncertainty_score":0.0034493804},"labels":[],"label_agreement":null},{"id":"W4379276081","doi":"10.33380/2305-2066-2023-12-2-146-153","title":"Phase I Pharmacokinetics Study of Drug for Infusion «Areplivir» (INN: Favipiravir) (LLC \"PROMOMED RUS\", Russia)","year":2023,"lang":"en","type":"article","venue":"Drug development & registration","topic":"Drug-Induced Hepatotoxicity and Protection","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Public Health Association","funders":"","keywords":"Pharmacokinetics; Pharmacology; Drug; Medicine; Favipiravir; Coronavirus disease 2019 (COVID-19); Internal medicine; Disease","score_opus":0.1664712180694004,"score_gpt":0.44900681623139765,"score_spread":0.28253559816199725,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379276081","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9708754,0.004654942,0.010669697,0.00040010182,0.00028211766,0.005255166,0.0024977264,0.0007138574,0.004650871],"genre_scores_gemma":[0.966458,0.0032177174,0.010627855,0.000794841,0.00015279972,0.0043751877,0.0048842337,0.0001514342,0.009337976],"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99958915,0.00015362393,0.000015776053,0.00010950209,0.000070929345,0.00006111402],"domain_scores_gemma":[0.9998091,0.00002477123,0.00004415528,0.000030094348,0.00003187035,0.000060115643],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00070355897,0.0009417013,0.0009098913,0.0002618823,0.0003117188,0.0005313392,0.0005285423,0.00066051324,0.002778702],"category_scores_gemma":[0.00045631223,0.00044297875,0.0006852144,0.0002309207,0.0004337946,0.00040228307,0.00020738342,0.0013910069,0.0010058144],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2286219,0.038513143,0.004931172,0.0012549708,0.00082502206,0.0002774246,0.00038133538,0.0036749619,0.565324,0.0011367965,0.008236168,0.14682306],"study_design_scores_gemma":[0.077788234,0.61007744,0.0279811,0.00014154911,0.0010173018,0.0022396666,0.00012883819,0.005959515,0.22728756,0.0005781527,0.04665701,0.00014360005],"about_ca_topic_score_codex":0.00046774454,"about_ca_topic_score_gemma":0.00060815824,"teacher_disagreement_score":0.002778702,"about_ca_system_score_codex":0.00046450054,"about_ca_system_score_gemma":0.0011794817,"threshold_uncertainty_score":0.009295702},"labels":[],"label_agreement":null},{"id":"W4379276111","doi":"10.33380/2305-2066-2023-12-2-135-145","title":"Simultaneous Determination of Nirmatrelvir and Ritonavir in Human Plasma by HPLC-MS/MS","year":2023,"lang":"en","type":"article","venue":"Drug development & registration","topic":"SARS-CoV-2 and COVID-19 Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Public Health Association","funders":"","keywords":"Ritonavir; Chromatography; Chemistry; Protein precipitation; Formic acid; Electrospray ionization; High-performance liquid chromatography; Tandem mass spectrometry; Mass spectrometry; Medicine; Viral load; Virology; Virus","score_opus":0.024230403010418983,"score_gpt":0.32547930253418916,"score_spread":0.3012488995237702,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379276111","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.61101866,0.061955392,0.28848454,0.001358396,0.0010289637,0.0017990966,0.008652894,0.0070304335,0.018671561],"genre_scores_gemma":[0.7375529,0.014518691,0.23029684,0.0022152448,0.000316541,0.0020719364,0.0045296685,0.0002346501,0.0082635395],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99795806,0.00045688162,0.00015311924,0.00064806856,0.0006850219,0.00009891035],"domain_scores_gemma":[0.99952626,0.00013642346,0.00010800416,0.000037932085,0.0001583213,0.000033113425],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014315404,0.0011775437,0.00068194827,0.0013710298,0.000574287,0.0006247831,0.00060935196,0.0014957786,0.0017431313],"category_scores_gemma":[0.0014875769,0.00049615063,0.00050422974,0.000729454,0.00042513054,0.00053789536,0.00046115418,0.00072987465,0.0012566969],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012887458,0.0003420276,0.006816818,0.0009487981,0.00030169726,0.00056837406,0.00019442906,0.0007809291,0.91748303,0.00060688774,0.0018446809,0.06882372],"study_design_scores_gemma":[0.0002465597,0.002390116,0.023350714,0.00020241334,0.0003937406,0.0070288084,0.00017979303,0.014618508,0.92145306,0.0011031035,0.028860645,0.00017254322],"about_ca_topic_score_codex":0.000454788,"about_ca_topic_score_gemma":0.0007836381,"teacher_disagreement_score":0.0017431313,"about_ca_system_score_codex":0.0004104573,"about_ca_system_score_gemma":0.0009057183,"threshold_uncertainty_score":0.007570803},"labels":[],"label_agreement":null},{"id":"W4379276540","doi":"10.33380/2305-2066-2023-12-2-62-72","title":"Development, Validation and Approbation Analytical Method for the Quantitative Determination of Taurine by HPLC-UV Method in the Test of Comparative Dissolution Kinetics","year":2023,"lang":"en","type":"article","venue":"Drug development & registration","topic":"Polyamine Metabolism and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Public Health Association","funders":"","keywords":"Taurine; Chromatography; Chemistry; Dissolution; Derivatization; Kinetics; High-performance liquid chromatography; Dosage form; Amino acid; Biochemistry; Organic chemistry","score_opus":0.04815994886209583,"score_gpt":0.372205494514972,"score_spread":0.32404554565287613,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379276540","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.20287557,0.023976654,0.7271046,0.001258232,0.0023364746,0.00833728,0.0026258144,0.006602505,0.024882944],"genre_scores_gemma":[0.31358954,0.0077264644,0.64252144,0.0012709063,0.00046230925,0.0062516895,0.003351069,0.00066745,0.024159122],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9846,0.0029041208,0.0010150521,0.0024261728,0.008693523,0.00036113392],"domain_scores_gemma":[0.994787,0.00082186103,0.00068804855,0.0006432447,0.0028625538,0.00019720687],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006177739,0.0018635385,0.0013298665,0.0026597145,0.001281197,0.0013600535,0.001635391,0.0030183396,0.0047704657],"category_scores_gemma":[0.007514421,0.0010022622,0.0013330176,0.0010997897,0.0014398029,0.0010034632,0.0010690785,0.0017950807,0.003769629],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00096014683,0.0007097093,0.004880375,0.0016006493,0.00019795429,0.0003784098,0.0003275384,0.00070947915,0.8795378,0.0010801493,0.0026921025,0.10692559],"study_design_scores_gemma":[0.00019023509,0.0023228426,0.011050441,0.00030782292,0.00037494162,0.002156949,0.00016319068,0.006057759,0.9299338,0.00031255686,0.046953883,0.00017558753],"about_ca_topic_score_codex":0.0013908275,"about_ca_topic_score_gemma":0.001889624,"teacher_disagreement_score":0.006177739,"about_ca_system_score_codex":0.0010439865,"about_ca_system_score_gemma":0.0030673586,"threshold_uncertainty_score":0.032671392},"labels":[],"label_agreement":null},{"id":"W4379276580","doi":"10.33380/2305-2066-2023-12-2-190-197","title":"Development and Validation of the ELISA Method for Neutralizing Anti-trastuzumab Antibodies Detection in Human Blood Serum","year":2023,"lang":"en","type":"article","venue":"Drug development & registration","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Public Health Association","funders":"","keywords":"Trastuzumab; Medicine; Immunogenicity; Antibody; Bioequivalence; Gold standard (test); Pharmacology; Cancer; Immunology; Internal medicine; Breast cancer; Pharmacokinetics","score_opus":0.04488240243248364,"score_gpt":0.34684753827839326,"score_spread":0.3019651358459096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379276580","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.331896,0.017943673,0.6309447,0.00119214,0.001084175,0.0028279522,0.0014284672,0.0019729452,0.010709924],"genre_scores_gemma":[0.50547415,0.007312467,0.47039518,0.0012226303,0.00023359066,0.0026024438,0.002014052,0.00015308398,0.010592415],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.98906004,0.0029159368,0.0006231543,0.0016234809,0.0054372726,0.00034005713],"domain_scores_gemma":[0.99712014,0.00070499076,0.00038905916,0.00022974989,0.001456687,0.00009942522],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0054984116,0.0011891503,0.000741912,0.002082404,0.00060525857,0.0010311337,0.0010695491,0.00231215,0.001227408],"category_scores_gemma":[0.0068006935,0.00072852545,0.0010917962,0.0008284458,0.0008877419,0.0005928868,0.00080799655,0.0015602881,0.0012557679],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033602415,0.00047498304,0.0044687386,0.0006828321,0.00010674575,0.00021322788,0.00027256034,0.00096137304,0.9517735,0.0008609662,0.0007527546,0.039096154],"study_design_scores_gemma":[0.00007269027,0.001655126,0.007039939,0.00017385848,0.00014984421,0.0015377931,0.00014044675,0.010026509,0.96476394,0.0003674783,0.0139788445,0.00009352496],"about_ca_topic_score_codex":0.0012659247,"about_ca_topic_score_gemma":0.001939638,"teacher_disagreement_score":0.0054984116,"about_ca_system_score_codex":0.00075094815,"about_ca_system_score_gemma":0.0016966915,"threshold_uncertainty_score":0.029078722},"labels":[],"label_agreement":null},{"id":"W4388760934","doi":"10.33380/2305-2066-2023-12-4-1467","title":"Technology Criteria for the Manufacturing of Rebamipide Film-coated Tablets","year":2023,"lang":"en","type":"article","venue":"Drug development & registration","topic":"Drug Solubulity and Delivery Systems","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Granulation; Anhydrous; Citric acid; Compaction; Raw material; Pulp and paper industry; Materials science; Chemical engineering; Chemistry; Food science; Composite material; Engineering; Organic chemistry","score_opus":0.1266812609583558,"score_gpt":0.41182161228398584,"score_spread":0.28514035132563004,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388760934","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.543407,0.019611815,0.3080735,0.0011642266,0.0006621109,0.016391912,0.0045924555,0.0013729825,0.10472403],"genre_scores_gemma":[0.5634493,0.010696545,0.39257059,0.0002980032,0.00013484758,0.007968917,0.004177499,0.0003176969,0.02038656],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99831545,0.00017888832,0.00029802855,0.00018679215,0.00092307985,0.00009786187],"domain_scores_gemma":[0.9986981,0.00026948313,0.00036101002,0.00010174286,0.00049624225,0.00007343851],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009371967,0.0009921564,0.0005758387,0.0013282456,0.00053587527,0.00093716726,0.00058652414,0.0010627715,0.008269826],"category_scores_gemma":[0.002021526,0.0003783393,0.000753294,0.00070931716,0.00043256057,0.0006082379,0.00061616354,0.0004956042,0.0038329822],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034256955,0.00009991957,0.00080881966,0.0010774944,0.00001197286,0.00071632955,0.00015095984,0.00062488223,0.96790546,0.0017739136,0.000759006,0.025728755],"study_design_scores_gemma":[0.00016607203,0.0029252756,0.013228604,0.00041433773,0.00013454386,0.002282783,0.00019666285,0.0037912386,0.8942543,0.00060942984,0.081935674,0.0000610869],"about_ca_topic_score_codex":0.0009789543,"about_ca_topic_score_gemma":0.0022066329,"teacher_disagreement_score":0.008269826,"about_ca_system_score_codex":0.00049811054,"about_ca_system_score_gemma":0.001103417,"threshold_uncertainty_score":0.027665317},"labels":[],"label_agreement":null}]}